Circulating Mature Megakaryocytes in an Unusual Case of BCR-ABL1-Positive CML

被引：1
|
作者：
Sharma, Saniya [1 ]
Sharma, Prashant [1 ]
Sachdeva, Man Updesh Singh [1 ]
Binota, Jogeshwar [1 ]
Sood, Anil [1 ]
Malhotra, Pankaj [2 ]
Varma, Neelam [1 ]
机构：
[1] Postgrad Inst Med Educ & Res PGIMER, Dept Hematol, Chandigarh 160012, India
[2] Postgrad Inst Med Educ & Res PGIMER, Dept Internal Med, Adult Clin Hematol Unit, Chandigarh 160012, India
来源：
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION | 2018年 / 34卷 / 04期
关键词：
LEUKEMIA; BLOOD;
D O I：
10.1007/s12288-018-0977-2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：762 / 764
页数：3
相关论文
共 50 条
  • [31] Promyelocytic Blast Phase of Chronic Myeloid Leukemia, BCR-ABL1-Positive: Points to be Considered at Diagnosis
    Kim, Bohyun
    Chi, Hyun Young
    Yoon, Young Ahn
    Choi, Young-Jin
    ANNALS OF LABORATORY MEDICINE, 2021, 41 (03) : 328 - 332
  • [32] The epigenetic effect of microRNA in BCR-ABL1-positive microvesicles during the transformation of normal hematopoietic transplants
    Shen, Na
    Jiang, Lin
    Li, Qing
    Cui, Jieke
    Zhou, Shu
    Cheng, Fanjun
    Zhong, Zhaodong
    Meng, Li
    You, Yong
    Zhu, Xiaojian
    Zou, Ping
    ONCOLOGY REPORTS, 2017, 38 (05) : 3278 - 3284
  • [33] Chronic myeloid leukaemia, BCR-ABL1-positive, in accelerated phase with marked eosinophilia with eosinophil atypia
    Richardson, Aida I.
    Skikne, Barry S.
    Woodroof, Janet
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 188 (05) : 599 - 599
  • [34] IKZF1 DELETION STATUS DISCRIMINATES FOR OUTCOME IN IMATINIBTREATED BCR-ABL1-POSITIVE CHILDHOOD ALL
    Van der Veer, A.
    Zaliova, M.
    Mottadelli, F.
    De Lorenzo, P.
    Te Kronnie, G.
    Harrison, C.
    Cave, H.
    Trka, J.
    Saha, V.
    Schrappe, M.
    Pieters, R.
    Biondi, A.
    Valsecchi, M.
    Stanulla, M.
    Den Boer, M.
    Cazzaniga, G.
    HAEMATOLOGICA, 2013, 98 : 462 - 463
  • [35] BCR-ABL1:ABL predicts outcomes in children with CML
    Bagcchi, Sanjeet
    LANCET ONCOLOGY, 2014, 15 (11): : E478 - E478
  • [36] A Phase I Study of Asciminib (ABL001) in Combination with Dasatinib and Prednisone for BCR-ABL1-Positive ALL in Adults
    Luskin, Marlise R.
    Stevenson, Kristen E.
    Mendez, Lourdes M.
    Wang, Eunice S.
    Wadleigh, Martha
    Garcia, Jacqueline S.
    Stone, Richard M.
    An, Hyun Hwan
    Hagopian, Ella
    Galinsky, Ilene
    Rae, Lindsey
    Leonard, Rebecca
    DeAngelo, Daniel J.
    Murakami, Mark A.
    BLOOD, 2021, 138
  • [37] Fine structure of translocation breakpoints within the major breakpoint region in BCR-ABL1-positive leukemias
    Burmeister, Thomas
    Groeger, Daniela
    Kuehn, Anett
    Hoelzer, Dieter
    Thiel, Eckhard
    Reinhardt, Richard
    DNA REPAIR, 2011, 10 (11) : 1131 - 1137
  • [38] Chronic myeloid leukemia, BCR-ABL1-positive, carrying NPM1 mutation - First case series from a single institution
    Young, Paul E.
    Kanagal-Shamanna, Rashmi
    Hu, Shimin
    Tang, Guilin
    Thakral, Beenu
    Daver, Naval
    Issa, Ghayas C.
    Medeiros, L. Jeffrey
    Konoplev, Sergej
    LEUKEMIA RESEARCH, 2021, 111
  • [39] CML - Not only BCR-ABL1 matters
    Rinke, Jenny
    Hochhaus, Andreas
    Ernst, Thomas
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2020, 33 (03)
  • [40] Identification of breakpoint hotspots in Philadelphia negative BCR/ABL positive CML
    Virgili, A.
    Brazma, D.
    Grace, C.
    Reid, A.
    Apperley, J.
    Nacheva, E. P.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 201 - 201
12345